Skip to main content

UBS Group AG

Position in CRDL — Cardiol Therapeutics Inc.

CIK 1610520 ZURICH, V8

Position in CRDL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$8,978
-$2,643 QoQ
Shares Held
8,471
-1.6% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#40
of 52 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 77% Shared 0% None 23%

Common Shares in CRDL Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

UBS Group AG holds $1,471,514,368 across 82 Drug Manufacturers - Specialty & Generic names. CRDL ranks #69 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CRDL

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,978 8,471
2026-03-31 $11,621 8,609
2025-12-31 $15,786 16,549
2025-09-30 $57,233 53,490
2025-06-30 $189,370 139,244
2025-03-31 $482,920 497,857
2024-12-31 $300,565 234,818
2024-09-30 $5,247 2,650
2024-06-30 $5,050 2,500
2024-03-31 $5,033 2,781
2023-12-31 $4,813 5,711
2023-09-30 $2,290 2,560
2023-06-30 $2,225 2,500
2023-03-31 $10,005 20,546
2022-12-31 $5,615 11,011
2022-09-30 $2,060 2,000
2022-06-30 $7,274 5,511
2022-03-31 $13,473 8,806
2021-12-31 $9,928 5,367